PHARMACOKINETICS OF ERGOTAMINE IN HEALTHY-VOLUNTEERS FOLLOWING ORAL AND RECTAL DOSING

被引：40
作者：
SANDERS, SW [1 ]
HAERING, N [1 ]
MOSBERG, H [1 ]
JAEGER, H [1 ]
机构：
[1] LAB GMBH & CO,D-7900 ULM,FED REP GER
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1986年 / 30卷 / 03期
关键词：
D O I：
10.1007/BF00541538
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：331 / 334
页数：4
相关论文
共 17 条
[1]   INVESTIGATION OF THE VENOCONSTRICTOR EFFECT OF 8' HYDROXYDIHYDROERGOTAMINE, THE MAIN METABOLITE OF DIHYDROERGOTAMINE, IN MAN [J].
AELLIG, WH .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (02) :239-242
[2]  
AELLIG WH, 1977, INT J CLIN PHARM BI, V15, P106
[3]   SYSTEMIC AVAILABILITY OF ERGOTAMINE TARTRATE AFTER 3 SUCCESSIVE DOSES AND DURING CONTINUOUS MEDICATION [J].
ALAHURULA, V ;
MYLLYLA, VV ;
ARVELA, P ;
KARKI, NT ;
HOKKANEN, E .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (05) :355-360
[4]   DETERMINATION OF ERGOT ALKALOIDS IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND FLUORESCENCE DETECTION [J].
EDLUND, PO .
JOURNAL OF CHROMATOGRAPHY, 1981, 226 (01) :107-115
[5]  
GIBALDI M, 1982, PHARMACOKINETICS
[6]   MEASUREMENT OF ERGOTAMINE IN HUMAN-PLASMA BY TRIPLE SECTOR QUADRUPOLE MASS-SPECTROMETRY WITH NEGATIVE-ION CHEMICAL IONIZATION [J].
HAERING, N ;
SETTLAGE, JA ;
SANDERS, SW ;
SCHUBERTH, R .
BIOMEDICAL MASS SPECTROMETRY, 1985, 12 (05) :197-199
[7]   EXERCISE-INDUCED INCREMENTS IN PLASMA-LEVELS OF PROPRANOLOL AND NORADRENALINE [J].
HURWITZ, GA ;
WEBB, JG ;
WALLE, T ;
BAI, SA ;
DANIELL, HB ;
GOURLEY, L ;
LOADHOLT, CB ;
GAFFNEY, TE .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (06) :599-608
[8]   LOW BIOAVAILABILITY OF ERGOTAMINE TARTRATE AFTER ORAL AND RECTAL ADMINISTRATION IN MIGRAINE SUFFERERS [J].
IBRAHEEM, JJ ;
PAALZOW, L ;
TFELTHANSEN, P .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (06) :695-699
[9]   QUANTITATIVE-DETERMINATION OF ERGOT ALKALOIDS IN BIOLOGICAL-FLUIDS BY RADIOIMMUNOASSAY [J].
KLEIMOLA, TT .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (03) :255-260
[10]   INFLUENCE OF FOOD-INTAKE ON PRESYSTEMIC CLEARANCE OF DRUGS [J].
MELANDER, A ;
MCLEAN, A .
CLINICAL PHARMACOKINETICS, 1983, 8 (04) :286-296
12